Advanced search

Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator

(1995) EUROPEAN HEART JOURNAL. 16(5). p.716-718
Author
Organization
Abstract
Superior vena cava syndrome is a rare, but nevertheless well known complication of permanent pacemaker implantation. Nowadays cardioverter defibrillators are also routinely implanted transvenously. A superior vena cava syndrome occurred in a 48-year-old female 2 years after implantation of cardioverter defibrillator. The clinical problem, in the presence of a predisposing thrombophilic condition (circulating lupus anticoagulant), resolved only partially after treatment with thrombolytics and oral anticoagulation. This syndrome should be recognized as a possible important complication of defibrillator therapy and requires lifelong anticoagulation.
Keywords
SUPERIOR VENA CAVA SYNDROME, THROMBOSIS, SUDDEN DEATH, IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)

Citation

Please use this url to cite or link to this publication:

Chicago
Dhondt, E, W Hutse, X Vanmeerhaeghe, and Luc Jordaens. 1995. “Superior Vena Cava Syndrome After Implantation of a Transvenous Cardioverter-defibrillator.” European Heart Journal 16 (5): 716–718.
APA
Dhondt, E, Hutse, W., Vanmeerhaeghe, X., & Jordaens, L. (1995). Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator. EUROPEAN HEART JOURNAL, 16(5), 716–718.
Vancouver
1.
Dhondt E, Hutse W, Vanmeerhaeghe X, Jordaens L. Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator. EUROPEAN HEART JOURNAL. 1995;16(5):716–8.
MLA
Dhondt, E, W Hutse, X Vanmeerhaeghe, et al. “Superior Vena Cava Syndrome After Implantation of a Transvenous Cardioverter-defibrillator.” EUROPEAN HEART JOURNAL 16.5 (1995): 716–718. Print.
@article{194149,
  abstract     = {Superior vena cava syndrome is a rare, but nevertheless well known complication of permanent pacemaker implantation. Nowadays cardioverter defibrillators are also routinely implanted transvenously. 
A superior vena cava syndrome occurred in a 48-year-old female 2 years after implantation of cardioverter defibrillator. The clinical problem, in the presence of a predisposing thrombophilic condition (circulating lupus anticoagulant), resolved only partially after treatment with thrombolytics and oral anticoagulation. This syndrome should be recognized as a possible important complication of defibrillator therapy and requires lifelong anticoagulation.},
  author       = {Dhondt, E and Hutse, W and Vanmeerhaeghe, X and Jordaens, Luc},
  issn         = {0195-668X},
  journal      = {EUROPEAN HEART JOURNAL},
  keyword      = {SUPERIOR VENA CAVA SYNDROME,THROMBOSIS,SUDDEN DEATH,IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)},
  language     = {eng},
  number       = {5},
  pages        = {716--718},
  title        = {Superior vena cava syndrome after implantation of a transvenous cardioverter-defibrillator},
  volume       = {16},
  year         = {1995},
}